Inorganic compound. Accumulates in bone tissue. Not metabolised.

(To be edited, initial data ST OCT 04) Biphosphonate used in Paget's disease. Accumulates in bone tissue where it inhibits bone resorbtion. Bioavailability about 6%. Excreted in unchanged form in urine.